In order to determine whether IL-4-induced Notch1/2 activation was due to the concomitant upregulated levels of Jag1 in CLL cells, we performed neutralization studies using anti-Jag1 antibodies, able to block Notch-Jag1 interactions among CLL cells. This evidence concerns the gene JAG1 and B-cell chronic lymphocytic leukemia.